Differential modulating effect of natural killer (NK) T cells on interferon-γ production and cytotoxic function of NK cells and its relationship with NK subsets in Chlamydia muridarum infection

Immunology

Volumn 134, Issue 2, 2011, Pages 172-184

  Zhao, Lei ^a,b   Gao, Xiaoling ^b   Peng, Ying ^a,b   Joyee, Antony G ^b   Bai, Hong ^b   Wang, Shuhe ^b   Yang, Jie ^b   Zhao, Weiming ^a   Yang, Xi ^a,b  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Chlamydia; Cytotoxicity; Interferon ; Natural killer cell; Natural killer T cell

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD11B ANTIGEN; CD27 ANTIGEN; CD69 ANTIGEN; GAMMA INTERFERON; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL EXPANSION; CELL INTERACTION; CELL KILLING; CELL SUBPOPULATION; CHLAMYDIA; CHLAMYDIASIS; CONTROLLED STUDY; CYTOTOXICITY; DEGRANULATION; FEMALE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; INTERFERON PRODUCTION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD11; ANTIGENS, CD1D; ANTIGENS, CD27; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NATURAL KILLER T-CELLS;

EID: 80052495962     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2011.03477.x     Document Type: Article

References (39)

1. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007; 25:297-336.
2. Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nat Rev 2002; 2:557-68.
3. -α/β T cells demonstrates preferential use of several Vβ genes and an invariant TCR α chain. J Exp Med 1993; 178:1-16.
4. - T cells. J Exp Med 1994; 180:1171-6.
5. Singh AK, Wilson MT, Hong S et al. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med 2001; 194:1801-11.
6. Exley MA, Bigley NJ, Cheng O et al. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J Leukoc Biol 2001; 69:713-8.
7. Smyth MJ, Thia KY, Street SE et al. Differential tumor surveillance by natural killer (NK) and NKT cells. J Exp Med 2000; 191:661-8.
8. Carnaud C, Lee D, Donnars O, Park SH, Beavis A, Koezuka Y, Bendelac A. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol 1999; 163:4647-50.
9. Tonti E, Galli G, Malzone C, Abrignani S, Casorati G, Dellabona P. NKT-cell help to B lymphocytes can occur independently of cognate interaction. Blood 2009; 113:370-6.
10. Joyee AG, Qiu H, Fan Y, Wang S, Yang X. Natural killer T cells are critical for dendritic cells to induce immunity in chlamydial pneumonia. Am J Respir Crit Care Med 2008; 178:745-56.
11. + dendritic cell subset in inducing type 1 immunity against infection. J Immunol 2010; 184:2095-106.
12. Cui J, Shin T, Kawano T et al. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science (New York, NY) 1997; 278:1623-6.
13. Kawano T, Cui J, Koezuka Y et al. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells. Proc Natl Acad Sci U S A 1998; 95:5690-3.
14. Metelitsa LS, Naidenko OV, Kant A, Wu HW, Loza MJ, Perussia B, Kronenberg M, Seeger RC. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J Immunol 2001; 167:3114-22.
15. Caligiuri MA. Human natural killer cells. Blood 2008; 112:461-9.
16. Hayakawa Y, Smyth MJ. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 2006; 176:1517-24.
17. Chiossone L, Chaix J, Fuseri N, Roth C, Vivier E, Walzer T. Maturation of mouse NK cells is a 4-stage developmental program. Blood 2009; 113:5488-96.
18. Walzer T, Chiossone L, Chaix J et al. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat Immunol 2007; 8:1337-44.
19. Gregoire C, Chasson L, Luci C, Tomasello E, Geissmann F, Vivier E, Walzer T. The trafficking of natural killer cells. Immunol Rev 2007; 220:169-82.
20. Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004; 294:15-22.
21. Uhrberg M. The CD107 mobilization assay: viable isolation and immunotherapeutic potential of tumor-cytolytic NK cells. Leukemia 2005; 19:707-9.
22. Eberl G, MacDonald HR. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur J Immunol 2000; 30:985-92.
23. Duthie MS, Kahn SJ. NK cell activation and protection occur independently of natural killer T cells during Trypanosoma cruzi infection. Int Immunol 2005; 17:607-13.
24. Mavoungou E, Poaty-Mavoungou V, Toure FS et al. Impairment of natural killer cell activity in Chlamydia trachomatis infected individuals. Trop Med Int Health 1999; 4:719-27.
25. Tseng CT, Rank RG. Role of NK cells in early host response to chlamydial genital infection. Infect Immun 1998; 66:5867-75.
26. Williams DM, Grubbs BG, Schachter J, Magee DM. Gamma interferon levels during Chlamydia trachomatis pneumonia in mice. Infect Immun 1993; 61:3556-8.
27. Joyee AG, Qiu H, Wang S, Fan Y, Bilenki L, Yang X. Distinct NKT cell subsets are induced by different Chlamydia species leading to differential adaptive immunity and host resistance to the infections. J Immunol 2007; 178:1048-58.
28. Hayakawa Y, Huntington ND, Nutt SL, Smyth MJ. Functional subsets of mouse natural killer cells. Immunol Rev 2006; 214:47-55.
29. Nagarajan NA, Kronenberg M. Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J Immunol 2007; 178:2706-13.
30. Ahlenstiel G, Titerence RH, Koh C et al. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-α-dependent manner. Gastroenterology 2010; 138:325-35 e1-2.
31. Rajagopalan S, Fu J, Long EO. Cutting edge: induction of IFN-γ production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J Immunol 2001; 167:1877-81.
32. Caraux A, Kim N, Bell SE et al. Phospholipase C-γ2 is essential for NK cell cytotoxicity and innate immunity to malignant and virally infected cells. Blood 2006; 107:994-1002.
33. Colucci F, Rosmaraki E, Bregenholt S et al. Functional dichotomy in natural killer cell signaling: Vav1-dependent and -independent mechanisms. J Exp Med 2001; 193:1413-24.
34. Bilenki L, Wang S, Yang J, Fan Y, Joyee AG, Yang X. NK T cell activation promotes Chlamydia trachomatis infection in vivo. J Immunol 2005; 175:3197-206.
35. Hook CE, Telyatnikova N, Goodall JC, Braud VM, Carmichael AJ, Wills MR, Gaston JS. Effects of Chlamydia trachomatis infection on the expression of natural killer (NK) cell ligands and susceptibility to NK cell lysis. Clin Exp Immunol 2004; 138:54-60.
36. Hook CE, Matyszak MK, Gaston JS. Infection of epithelial and dendritic cells by Chlamydia trachomatis results in IL-18 and IL-12 production, leading to interferon-γ production by human natural killer cells. FEMS Immunol Med Microbiol 2005; 45:113-20.
37. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev 2002; 2:957-64.
38. Ferlazzo G, Morandi B, D'Agostino A, Meazza R, Melioli G, Moretta A, Moretta L. The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur J Immunol 2003; 33:306-13.
39. Della Chiesa M, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, Moretta A. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur J Immunol 2003; 33:1657-66.